[Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke].
BACKGROUND
Decreased activity of natural anticoagulants (antithrombin-lll, protein C, protein S) rarely causes cerebral ischaemia, however it can be found frequently in acute phase of ischaemic stroke. The authors' aim was to investigate whether the decreased activity of natural anticoagulants is accompanied by worsening of symptoms in ischaemic stroke.


METHODS
Sixty-eight acute ischaemic stroke patients were investigated. Severity of symptoms were assessed and followed by the NIH Stroke Scale. Antithrombin-Ill, protein C, protein S activities, and concentration of C-reactive protein (CRP) were measured within 48 hours after onset of ischaemic stroke.


RESULTS
Progressing stroke was found in 29% of patients. Decreased activity of at least one natural anticoagulant proteins was present in 31% of patients. Progression of stroke symptoms occurred in 76% of patients with decreased natural anticoagulant activity, while this proportion was only 9% in those with normal natural coagulation inhibitor protein activity (p < 0.01). Progressing stroke was also more frequent in patients with elevated CRP value (60%) than in those with normal CRP level (11%; p < 0.05). Decreased activity of natural anticoagulants was more frequent in patients with elevated CRP concentration compared with patients with normal CRP.


CONCLUSIONS
The results demonstrate the importance of decreased activity of natural anticoagulants in acute phase of ischaemic stroke. This abnormality was present in about 1/3 of stroke patients. The decreased activity of natural coagulant inhibitor proteins may play an important role in development of progressing stroke thus indicating unfavourable outcome.
Oláh
László
L
Debreceni Egyetem, Orvos- es Egészségtudományi Centrum, Neurológiai Klinika, Debrecen. olah@jaguar.dote.hu
Csépány
Tünde
T
Bereczky
Zsuzsanna
Z
Kerényi
Adrienne
A
Misz
Mária
M
Kappelmayer
János
J
Csiba
László
L
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000378:metabolism*; D001779:Blood Coagulation Factors / Q000037:antagonists & inhibitors*; D002545:Brain Ischemia / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011486:Protein C / Q000378:metabolism*; D017293:Protein S / Q000378:metabolism*; D012720:Severity of Illness Index; D020521:Stroke / Q000097:blood* / Q000209:etiology / Q000378:metabolism
D001779:Blood Coagulation Factors; D011486:Protein C; D017293:Protein S; D000990:Antithrombin III